We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000776:SZSEGF Securities Co., Ltd. Analysis

Data as of 2026-05-22 - not real-time

CN¥19.05

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

GF Securities trades at CNY 19.05, well below its DCF‑derived fair value of roughly CNY 37.9, implying a potential upside of about 40 %. Its trailing P/E of 9.9 is far under the industry average of 16.8, reinforcing the valuation gap. The company posted an 70 % year‑over‑year revenue surge and maintains strong gross (55.7 %) and operating (55 %) margins. A dividend yield of 2.6 % with a modest payout ratio of 26 % adds income appeal. However, a debt‑to‑equity ratio above 290 % signals a leverage concern that investors must monitor.
Technically, the stock sits just above the 20‑day SMA (20.38) and near the identified support level of 18.91, while the resistance 21.73 looms above the current price. The MACD histogram is negative and the signal line is bearish, suggesting short‑term downside pressure. RSI at 34.8 points to a mildly oversold condition, offering a possible rebound trigger. Volatility over the past month is elevated at 32 % but beta ≈0.43, indicating limited market‑wide sensitivity. Combining the valuation upside with the dividend safety and modest technical support leads to an cautiously bullish outlook.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price near support at 18.91
  • RSI indicating mild oversold condition
  • Attractive dividend yield with low payout

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Undervaluation relative to DCF and peers
  • Strong profit margins and revenue growth
  • High leverage requiring monitoring

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF upside of ~40 %
  • Low beta indicating defensive characteristics
  • Sustainable dividend and stable cash position

Key Metrics & Analysis

Financial Health

Revenue Growth70.10%
Profit Margin39.15%
P/E Ratio9.9
ROE10.24%
ROA1.76%
Debt/Equity290.43
P/B Ratio1.1
Op. Cash FlowCN¥4.8B
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI34.8
SupportCN¥18.91
ResistanceCN¥21.73
MA 20CN¥20.38
MA 50CN¥19.52
MA 200CN¥21.09
MACDBearish
VolumeDecreasing
Fear & Greed Index91.73

Valuation

Fair ValueCN¥37.87
Target PriceCN¥26.57
Upside/Downside39.45%
GradeUndervalued
TypeBlend
Dividend Yield2.59%

Risk Assessment

Beta0.43
Volatility32.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.